Point Of Care Molecular Diagnostics Market Size And Share

  • Report Code : TIPRE00003144
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 208
Buy Now

Point-of-Care Molecular Diagnostics Market Size, Top Players, and Forecast by 2028

Buy Now

Point-of-Care Molecular Diagnostics Market Report Point-of-Care Molecular Diagnostics Market Scope and Analysis Point-of-Care Molecular Diagnostics Market Size and Share

Point-of-Care Molecular Diagnostics Market: Strategic Insights

Point-of-Care Molecular Diagnostics Market

  • CAGR (2021 - 2028)
    13.4%
  • Market Size 2021
    US$ 2.23 Billion
  • Market Size 2028
    US$ 5.38 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
  • Rising Incidences of Infectious Diseases
FUTURE TRENDS
  • Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits Across Residential Setting
OPPORTUNITIES
  • Rising R&D and Innovation in Point- of-Care Molecular Diagnostics

Key Players

  • bioM rieux SA
  • F Hoffmann La Roche Ltd
  • Danaher Corporation
  • Enzo Biochem Inc
  • Abbott
  • binx health Inc
  • Meridian BioScience Inc
  • Biocartis
  • Quidel Corporation

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product & Services
  • Assays and Kits
  • Instruments
  • Services and Software
Technology
  • PCR
  • Isothermal Nucleic Acid Amplification Technology
Other Technologies)
    Application
    • Infectious Diseases
    • Oncology
    • Hematology
    • Prenatal Testing
    • Endocrinology
    • Other Applications